Tornos Ascends To Zimmer Biomet CEO As Hanson Leaves For 3M Spinoff
Ivan Tornos will shift from COO to CEO of Zimmer Biomet now that former CEO Bryan Hanson has accepted the CEO job at 3M’s health care spinoff.
You may also be interested in...
The cuts will cost up to $150m, but the orthopedics company expects to save $200m annually by the end of 2025. The company also announced plans to reduce inventories to prevent excess and obsolescence.
Medtech Insight's News We're Watching highlights medtech industry news developments you may have missed over the last few weeks.
This week, cardiac monitoring firm AngelMed announced its new name; Tempus nabbed FDA approval for its tumor profiling test; and iRhythm revealed that it’s been subpoenaed by the US Department of Justice.